Bill > S09279

This bill, known as the "bioterrorism prevention act," requires entities that create and distribute synthetic genes, referred to as "gene synthesis providers," and companies that manufacture equipment for this purpose to follow rules and regulations set by the department of health. These regulations will include guidelines for identifying potentially dangerous genetic sequences, vetting customers, and keeping records of synthesized or delivered genes. The department will base these rules on established industry standards and recommendations from organizations like the international gene synthesis consortium. A "gene synthesis provider" is defined as any business that makes and gives synthetic nucleic acids (like DNA or RNA) to customers or distributors.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/S9279